Jet color chemistry and anomalous baryon production in AAAA-collisions

We study anomalous high-$p_T$ baryon production in $AA$-collisions due to formation of the two parton collinear $gq$ system in the anti-sextet color state for quark jets and $gg$ system in the decuplet/anti-decuplet color states for gluon jets. Fragmentation of these states, which are absent for $NN$-collisions, after escaping from the quark-gluon plasma leads to baryon production. Our qualitative estimates show that this mechanism can be potentially important at RHIC and LHC energies.Comment: 20 pages, 4 figures, Eur.Phys.J. versio

Transformations of actinides fission product yields due to post scission emission of nuclear particles:232Th

The "many ensembles" method was proposed to investigate the influence of nuclear particles' post-scission emission on mass and charge distributions of fission products. The post scission approximation had been used; each of these ensembles consists of the fission fragments after emission of chains of different lengths, both the beta (β) particles and neutrons. The theory allows one to find the most probable two fragment clusters of fission products and study their evolution after the post-scission emission of nuclear particles. The isotopeThe accepted manuscript in pdf format is listed with the files at the bottom of this page. The presentation of the authors' names and (or) special characters in the title of the manuscript may differ slightly between what is listed on this page and what is listed in the pdf file of the accepted manuscript; that in the pdf file of the accepted manuscript is what was submitted by the author

Global Impact of COVID-19 on Stroke Care and IV Thrombolysis

OBJECTIVE: To measure the global impact of COVID-19 pandemic on volumes of IV thrombolysis (IVT), IVT transfers, and stroke hospitalizations over 4 months at the height of the pandemic (March 1 to June 30, 2020) compared with 2 control 4-month periods. METHODS: We conducted a cross-sectional, observational, retrospective study across 6 continents, 70 countries, and 457 stroke centers. Diagnoses were identified by their ICD-10 codes or classifications in stroke databases. RESULTS: There were 91,373 stroke admissions in the 4 months immediately before compared to 80,894 admissions during the pandemic months, representing an 11.5% (95% confidence interval [CI] -11.7 to -11.3, p < 0.0001) decline. There were 13,334 IVT therapies in the 4 months preceding compared to 11,570 procedures during the pandemic, representing a 13.2% (95% CI -13.8 to -12.7, p < 0.0001) drop. Interfacility IVT transfers decreased from 1,337 to 1,178, or an 11.9% decrease (95% CI -13.7 to -10.3, p = 0.001). Recovery of stroke hospitalization volume (9.5%, 95% CI 9.2-9.8, p < 0.0001) was noted over the 2 later (May, June) vs the 2 earlier (March, April) pandemic months. There was a 1.48% stroke rate across 119,967 COVID-19 hospitalizations. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was noted in 3.3% (1,722/52,026) of all stroke admissions. CONCLUSIONS: The COVID-19 pandemic was associated with a global decline in the volume of stroke hospitalizations, IVT, and interfacility IVT transfers. Primary stroke centers and centers with higher COVID-19 inpatient volumes experienced steeper declines. Recovery of stroke hospitalization was noted in the later pandemic months. © 2021 American Academy of Neurology